USANA Health Sciences Inc. (USNA - Snapshot Report) shares are down nearly 4% on Thursday as Bill Ackman levied accusations of being a pyramid scheme on HerbaLife. With and a long-term expected earnings growth rate of 18%, this Zacks #1 Rank (Strong Buy) still looks like a solid growth pick.
USANA Health Sciences Inc. (USNA - Snapshot Report) shares are down nearly 4% on Thursday as Bill Ackman levied accusations of being a pyramid scheme on HerbaLife. With and a long-term expected earnings growth rate of 18%, this Zacks #1 Rank (Strong Buy) still looks like a solid growth pick.
Share this Article
Recommended